Tharimmune, INC DEF 14A proxy statements

Canton Strategic Holdings, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders to be held virtually on July 13, 2026.

Tharimmune, Inc. issued a supplement to its proxy statement clarifying the independent status of two director nominees for its upcoming Special Meeting of Stockholders.

Tharimmune, Inc. calls a special meeting to vote on new directors, significant equity issuances for strategic advisors and private placements, and an expansion of its equity incentive plan.

Tharimmune, Inc. calls a special meeting to vote on increasing authorized common stock, expanding its equity incentive plan, and authorizing future non-public offerings to support growth and capital needs.

Tharimmune Inc. issues a supplement to its proxy statement to correct an error related to the reported beneficial ownership of shares by Vincent LoPriore.

Tharimmune, Inc. has filed a definitive proxy statement with the Securities and Exchange Commission.

Tharimmune, Inc. is soliciting proxies for its 2025 annual meeting, featuring proposals to elect directors, ratify the appointment of its accounting firm, and approve an amendment to its equity incentive plan.

Tharimmune, Inc. has filed a definitive proxy statement with the SEC.

Tharimmune, Inc. has filed a definitive proxy statement with the SEC.

Tharimmune, Inc. is asking stockholders to vote on key proposals at its upcoming annual meeting, including a reverse stock split to regain Nasdaq compliance and an amended equity incentive plan to attract and retain talent.